Catalyst Wire Dossier Catalyst Wire Dossier

Zalviso System

sufentanil · Talphera, Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zalviso System, covering 2018-08-08 to 2018-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Overall Performance of the Zalviso System™ (Sufentanil Sublingual Tablet System) 15 mcg [Phase 3]

See pricing